Daily non-political popular news in brief.

Sleep apnea increases risk of diabetes and hypertension in pregnant women

05-22-2007 · EurekAlert!

Sleep apnea is associated with a greatly increased incidence of pregnancy-induced diabetes and high blood pressure, according to a study presented at the American Thoracic Society 2007 International Conference, on Wednesday, May 22.

Keywords: sleep, apnea, risk, diabetes, hypertension, pregnant, women, diabete

« Previous | Next »

Similar news on "Sleep apnea increases risk of diabetes and hypertension in pregnant women":

Childhood sleep-disordered breathing disproportionately affects obese and African-Americans
12-01-2007 · EurekAlert!
Sleep-disordered breathing, which can include various sleep behaviors ranging in severity from snoring to obstructive sleep apnea, disproportionately affects children who are overweight and African-American, according to a new study published in the December 2007 edition of Otolaryngology -- Head and Neck Surgery. Obstructive sleep apnea can pose serious health threats, including hypertension and higher risk for cardiac disease.
Similar news · Read more »
Prenatal stress keeps infants, toddlers up at night, study says
07-27-2007 · EurekAlert!
Anxious or depressed mothers-to-be are at increased risk of having children who will experience sleep problems in infancy and toddlerhood, finds a study that published this month in Early Human Development. The study tracked 14,000 pregnant women (and an index child) living in Avon, England and found that women classified as "mood disturbed" during their pregnancies were 40 percent more likely to have a child with significant trouble sleeping.
Similar news · Read more »
Grapes, soy and kudzu blunt some menopausal side effects
08-08-2007 · EurekAlert!
Menopausal women are at relatively high risk for memory loss, hypertension and diabetes. A decade ago, the standard treatment for these problems was long-term hormone replacement therapy. Since then, studies have shown that extensive use of HRT is associated with significant adverse effects. As a result, alternatives have been sought. One research lab investigating grape, soy and kudzu has found they can blunt cognitive loss, hypertension and insulin resistance in an experimental model.
Similar news · Read more »
Sleep apnea may increase risk of diabetes
05-20-2007 · EurekAlert!
Researchers at the Yale University School of Medicine have found that patients with obstructive sleep apnea are at increased risk for developing of type 2 diabetes, independent of other risk factors. The findings are being presented at the American Thoracic Society 2007 International Conference, on Monday, May 21.
Similar news · Read more »
Risk factors for developing complications from sleep apnea surgery
10-16-2006 · EurekAlert!
Patients undergoing surgery to correct sleep apnea are more likely to have complications if their condition is severe, they have a high body mass index, they have other medical problems or they are undergoing certain other surgical procedures at the same time, according to a report in the October issue of Archives of Otolaryngology -- Head & Neck Surgery, one of the JAMA/Archives journals.
Similar news · Read more »
Diabetes risk factors develop earlier in women than men
02-19-2007 · EurekAlert!
The 'diabetes clock' may start ticking in women years in advance of a medical diagnosis of the disease, new research has shown.
Similar news · Read more »
Pregnant women with placental infection have doubled risk of recurrence
11-30-2006 · UT Southwestern Medical Center
Pregnant women who develop an infection of the placenta or nearby membranes in their first pregnancy have twice the risk of getting it in their second pregnancy, researchers at UT Southwestern Medical Center have found.
Similar news · Read more »
Passive smoking increases sleep disturbance among pregnant women
09-01-2007 · EurekAlert!
Pregnant women exposed to passive smoking are more likely to have sleep disturbances such as subjective insufficient sleep, difficulty in initiating sleep, short sleep duration, and snoring loudly or breathing uncomfortably, according to a study published in the September 1 issue of the journal SLEEP.
Similar news · Read more »
Study explains why patients with OSA are at higher risk for cardiovascular disease
06-01-2007 · EurekAlert!
Researchers have found that patients with obstructive sleep apnea have higher levels of a type of dead cells (apoptotic cells) from the lining (endothelium) of their blood vessels circulating in their bloodstream than people who do not have OSA. The finding may help explain why those with OSA are at higher risk for cardiovascular disease.
Similar news · Read more »
Advance in understanding of blood pressure gene could lead to new treatments
02-04-2007 · EurekAlert!
Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
Similar news · Read more »